Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Science|March 23, 2021
Antibody-drug conjugate MORAb-202 exhibits long-lasting antitumor efficacy in TNBC PDx modelsKeiji Furuuchi, Katherine Rybinski, James Fulmer, et al.
Oncotarget|September 2, 2015
Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculatureKatherine Rybinski, Hongxia Z Imtiyaz, Barrie Mittica, et al.
Molecular Cancer Therapeutics|September 29, 2018
MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor ActivityXin Cheng, Jing Li, Keigo Tanaka, et al.
Antibody Therapeutics|July 22, 2024
Preclinical studies of BB-1701, a HER2-targeting eribulin-containing ADC with potent bystander effect and ICD activityYang Wang, Bing Xia, Lixia Cao, et al.
Pageof 3